Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
by
Takegami, Yujiro
, Oshima, Masanobu
, Oshima, Hiroko
, Park, Jun-Won
, Jenkins, Nancy A.
, Nakayama, Mizuho
, Ali, Mohamed A. E.
, Copeland, Neal G.
, Yamamoto, Daisuke
, Takeda, Haruna
, Kataoka, Shiho
, An, Tadaichi
in
Activin receptors
/ Adenomatous polyposis coli
/ Animal models
/ Animals
/ Biological Sciences
/ Cancer
/ Cell Line, Tumor
/ Colorectal cancer
/ Colorectal carcinoma
/ Colorectal Neoplasms - genetics
/ Colorectal Neoplasms - metabolism
/ Colorectal Neoplasms - pathology
/ CRISPR
/ CRISPR-Cas Systems
/ Datasets
/ Gene Expression Profiling
/ Gene Knockout Techniques
/ Gene sequencing
/ Genes
/ Genomes
/ Growth factors
/ Humans
/ Intestine
/ Medical Sciences
/ Metastases
/ Mice
/ Mice, Inbred NOD
/ Mutagenesis
/ Mutation
/ Neoplasm Proteins - biosynthesis
/ Neoplasm Proteins - genetics
/ Organoids
/ Organoids - metabolism
/ Organoids - pathology
/ Organs
/ PNAS Plus
/ Receptors
/ Sensitizing
/ Transforming growth factor
/ Transforming growth factor-b
/ Tumor suppressor genes
/ Tumorigenesis
/ Tumors
/ Xenografts
/ Xenotransplantation
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
by
Takegami, Yujiro
, Oshima, Masanobu
, Oshima, Hiroko
, Park, Jun-Won
, Jenkins, Nancy A.
, Nakayama, Mizuho
, Ali, Mohamed A. E.
, Copeland, Neal G.
, Yamamoto, Daisuke
, Takeda, Haruna
, Kataoka, Shiho
, An, Tadaichi
in
Activin receptors
/ Adenomatous polyposis coli
/ Animal models
/ Animals
/ Biological Sciences
/ Cancer
/ Cell Line, Tumor
/ Colorectal cancer
/ Colorectal carcinoma
/ Colorectal Neoplasms - genetics
/ Colorectal Neoplasms - metabolism
/ Colorectal Neoplasms - pathology
/ CRISPR
/ CRISPR-Cas Systems
/ Datasets
/ Gene Expression Profiling
/ Gene Knockout Techniques
/ Gene sequencing
/ Genes
/ Genomes
/ Growth factors
/ Humans
/ Intestine
/ Medical Sciences
/ Metastases
/ Mice
/ Mice, Inbred NOD
/ Mutagenesis
/ Mutation
/ Neoplasm Proteins - biosynthesis
/ Neoplasm Proteins - genetics
/ Organoids
/ Organoids - metabolism
/ Organoids - pathology
/ Organs
/ PNAS Plus
/ Receptors
/ Sensitizing
/ Transforming growth factor
/ Transforming growth factor-b
/ Tumor suppressor genes
/ Tumorigenesis
/ Tumors
/ Xenografts
/ Xenotransplantation
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
by
Takegami, Yujiro
, Oshima, Masanobu
, Oshima, Hiroko
, Park, Jun-Won
, Jenkins, Nancy A.
, Nakayama, Mizuho
, Ali, Mohamed A. E.
, Copeland, Neal G.
, Yamamoto, Daisuke
, Takeda, Haruna
, Kataoka, Shiho
, An, Tadaichi
in
Activin receptors
/ Adenomatous polyposis coli
/ Animal models
/ Animals
/ Biological Sciences
/ Cancer
/ Cell Line, Tumor
/ Colorectal cancer
/ Colorectal carcinoma
/ Colorectal Neoplasms - genetics
/ Colorectal Neoplasms - metabolism
/ Colorectal Neoplasms - pathology
/ CRISPR
/ CRISPR-Cas Systems
/ Datasets
/ Gene Expression Profiling
/ Gene Knockout Techniques
/ Gene sequencing
/ Genes
/ Genomes
/ Growth factors
/ Humans
/ Intestine
/ Medical Sciences
/ Metastases
/ Mice
/ Mice, Inbred NOD
/ Mutagenesis
/ Mutation
/ Neoplasm Proteins - biosynthesis
/ Neoplasm Proteins - genetics
/ Organoids
/ Organoids - metabolism
/ Organoids - pathology
/ Organs
/ PNAS Plus
/ Receptors
/ Sensitizing
/ Transforming growth factor
/ Transforming growth factor-b
/ Tumor suppressor genes
/ Tumorigenesis
/ Tumors
/ Xenografts
/ Xenotransplantation
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
Journal Article
CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
2019
Request Book From Autostore
and Choose the Collection Method
Overview
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths worldwide. Several genome sequencing studies have provided comprehensive CRC genomic datasets. Likewise, in our previous study, we performed genome-wide Sleeping Beauty transposon-based mutagenesis screening in mice and provided comprehensive datasets of candidate CRC driver genes. However, functional validation for most candidate CRC driver genes, which were commonly identified from both human and mice, has not been performed. Here, we describe a platform for functionally validating CRC driver genes that utilizes CRISPR-Cas9 in mouse intestinal tumor organoids and human CRC-derived organoids in xenograft mouse models. We used genetically defined benign tumor-derived organoids carrying 2 frequent gene mutations (Apc and Kras mutations), which act in the early stage of CRC development, so that we could clearly evaluate the tumorigenic ability of the mutation in a single gene. These studies showed that Acvr1b, Acvr2a, and Arid2 could function as tumor suppressor genes (TSGs) in CRC and uncovered a role for Trp53 in tumor metastasis. We also showed that co-occurrent mutations in receptors for activin and transforming growth factor-β (TGF-β) synergistically promote tumorigenesis, and shed light on the role of activin receptors in CRC. This experimental system can also be applied to mouse intestinal organoids carrying other sensitizing mutations as well as organoids derived from other organs, which could further contribute to identification of novel cancer driver genes and new drug targets.
Publisher
National Academy of Sciences
Subject
/ Animals
/ Cancer
/ Colorectal Neoplasms - genetics
/ Colorectal Neoplasms - metabolism
/ Colorectal Neoplasms - pathology
/ CRISPR
/ Datasets
/ Genes
/ Genomes
/ Humans
/ Mice
/ Mutation
/ Neoplasm Proteins - biosynthesis
/ Neoplasm Proteins - genetics
/ Organs
/ Transforming growth factor-b
/ Tumors
This website uses cookies to ensure you get the best experience on our website.